Literature DB >> 33513350

Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function.

Mai Luo1, Jessica N Spradlin1, Lydia Boike1, Bingqi Tong1, Scott M Brittain2, Jeffrey M McKenna2, John A Tallarico2, Markus Schirle2, Thomas J Maimone3, Daniel K Nomura4.   

Abstract

The translation of functionally active natural products into fully synthetic small-molecule mimetics has remained an important process in medicinal chemistry. We recently discovered that the terpene natural product nimbolide can be utilized as a covalent recruiter of the E3 ubiquitin ligase RNF114 for use in targeted protein degradation-a powerful therapeutic modality within modern-day drug discovery. Using activity-based protein profiling-enabled covalent ligand-screening approaches, here we report the discovery of fully synthetic RNF114-based recruiter molecules that can also be exploited for PROTAC applications, and demonstrate their utility in degrading therapeutically relevant targets, such as BRD4 and BCR-ABL, in cells. The identification of simple and easily manipulated drug-like scaffolds that can mimic the function of a complex natural product is beneficial in further expanding the toolbox of E3 ligase recruiters, an area of great importance in drug discovery and chemical biology.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PROTAC; RNF114; chemoproteomics; covalent ligand; cysteine; targeted protein degradation

Mesh:

Substances:

Year:  2021        PMID: 33513350      PMCID: PMC8052289          DOI: 10.1016/j.chembiol.2021.01.005

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  26 in total

1.  Enantioselective phase-transfer catalysis: synthesis of pyrazolines.

Authors:  Olivier Mahé; Isabelle Dez; Vincent Levacher; Jean-François Brière
Journal:  Angew Chem Int Ed Engl       Date:  2010-09-17       Impact factor: 15.336

Review 2.  Natural Products as Sources of New Drugs from 1981 to 2014.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2016-02-07       Impact factor: 4.050

3.  ProLuCID: An improved SEQUEST-like algorithm with enhanced sensitivity and specificity.

Authors:  T Xu; S K Park; J D Venable; J A Wohlschlegel; J K Diedrich; D Cociorva; B Lu; L Liao; J Hewel; X Han; C C L Wong; B Fonslow; C Delahunty; Y Gao; H Shah; J R Yates
Journal:  J Proteomics       Date:  2015-07-11       Impact factor: 4.044

Review 4.  Induced protein degradation: an emerging drug discovery paradigm.

Authors:  Ashton C Lai; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2016-11-25       Impact factor: 84.694

5.  A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL.

Authors:  Bingqi Tong; Jessica N Spradlin; Luiz F T Novaes; Erika Zhang; Xirui Hu; Malte Moeller; Scott M Brittain; Lynn M McGregor; Jeffrey M McKenna; John A Tallarico; Markus Schirle; Thomas J Maimone; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2020-06-25       Impact factor: 5.100

6.  Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening.

Authors:  Daniel A Bachovchin; Tianyang Ji; Weiwei Li; Gabriel M Simon; Jacqueline L Blankman; Alexander Adibekian; Heather Hoover; Sherry Niessen; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-17       Impact factor: 11.205

7.  Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications.

Authors:  Carl C Ward; Jordan I Kleinman; Scott M Brittain; Patrick S Lee; Clive Yik Sham Chung; Kenneth Kim; Yana Petri; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

8.  Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.

Authors:  Jessica N Spradlin; Xirui Hu; Carl C Ward; Scott M Brittain; Michael D Jones; Lisha Ou; Milton To; Andrew Proudfoot; Elizabeth Ornelas; Mikias Woldegiorgis; James A Olzmann; Dirksen E Bussiere; Jason R Thomas; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Thomas J Maimone; Daniel K Nomura
Journal:  Nat Chem Biol       Date:  2019-06-17       Impact factor: 15.040

9.  A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles.

Authors:  Chu Wang; Eranthie Weerapana; Megan M Blewett; Benjamin F Cravatt
Journal:  Nat Methods       Date:  2013-12-01       Impact factor: 28.547

View more
  15 in total

Review 1.  Advances in targeting 'undruggable' transcription factors with small molecules.

Authors:  Matthew J Henley; Angela N Koehler
Journal:  Nat Rev Drug Discov       Date:  2021-05-18       Impact factor: 84.694

Review 2.  Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras.

Authors:  Chunlong Zhao; Frank J Dekker
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-22

3.  Deubiquitinase-targeting chimeras for targeted protein stabilization.

Authors:  Nathaniel J Henning; Lydia Boike; Jessica N Spradlin; Carl C Ward; Gang Liu; Erika Zhang; Bridget P Belcher; Scott M Brittain; Matthew J Hesse; Dustin Dovala; Lynn M McGregor; Rachel Valdez Misiolek; Lindsey W Plasschaert; David J Rowlands; Feng Wang; Andreas O Frank; Daniel Fuller; Abigail R Estes; Katelyn L Randal; Anoohya Panidapu; Jeffrey M McKenna; John A Tallarico; Markus Schirle; Daniel K Nomura
Journal:  Nat Chem Biol       Date:  2022-02-24       Impact factor: 16.174

4.  Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications.

Authors:  Nathaniel J Henning; Andrew G Manford; Jessica N Spradlin; Scott M Brittain; Erika Zhang; Jeffrey M McKenna; John A Tallarico; Markus Schirle; Michael Rape; Daniel K Nomura
Journal:  J Am Chem Soc       Date:  2022-01-07       Impact factor: 16.383

5.  Covalent PROTACs: the best of both worlds?

Authors:  Neil P Grimster
Journal:  RSC Med Chem       Date:  2021-07-15

6.  Ligandability of E3 Ligases for Targeted Protein Degradation Applications.

Authors:  Bridget P Belcher; Carl C Ward; Daniel K Nomura
Journal:  Biochemistry       Date:  2021-09-02       Impact factor: 3.162

7.  Drugging Fuzzy Complexes in Transcription.

Authors:  Bonnie G Su; Matthew J Henley
Journal:  Front Mol Biosci       Date:  2021-12-21

Review 8.  E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points.

Authors:  Aleša Bricelj; Christian Steinebach; Robert Kuchta; Michael Gütschow; Izidor Sosič
Journal:  Front Chem       Date:  2021-07-05       Impact factor: 5.221

Review 9.  PROTAC targeted protein degraders: the past is prologue.

Authors:  Miklós Békés; David R Langley; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2022-01-18       Impact factor: 112.288

Review 10.  Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms.

Authors:  Frances P Rodriguez-Rivera; Samuel M Levi
Journal:  ACS Cent Sci       Date:  2021-06-16       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.